Pegfilgrastim: current and future perspectives in the treatment of chemotherapy-induced neutropenia.

about

Pegfilgrastim: current and future perspectives in the treatment of chemotherapy-induced neutropenia.

Item

http://www.wikidata.org/entity/Q36677460

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Pegfilgrastim: current and fut ...... motherapy-induced neutropenia.

@ast

Pegfilgrastim: current and fut ...... motherapy-induced neutropenia.

@en

type

Item

label

Pegfilgrastim: current and fut ...... motherapy-induced neutropenia.

@ast

Pegfilgrastim: current and fut ...... motherapy-induced neutropenia.

@en

prefLabel

Pegfilgrastim: current and fut ...... motherapy-induced neutropenia.

@ast

Pegfilgrastim: current and fut ...... motherapy-induced neutropenia.

@en

P1476

Pegfilgrastim: current and fut ...... motherapy-induced neutropenia.

@en

P2093

Giulio Cerea

http://www.w3.org/2001/XMLSchema#string

Ilaria Schiavetto

http://www.w3.org/2001/XMLSchema#string

Maria Rosaria Maugeri

http://www.w3.org/2001/XMLSchema#string

Paolo Pedrazzoli

http://www.w3.org/2001/XMLSchema#string

Riccardo Ricotta

http://www.w3.org/2001/XMLSchema#string

Salvatore Siena

http://www.w3.org/2001/XMLSchema#string

P2860

14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.

Comparison of G-CSF and GM-CSF adverse event profiles in office-based practices: preliminary study results.

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.

First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study.

Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomized controlled trials.

Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy.

Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.

Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients.

Therapeutic use of granulocyte and granulocyte-macrophage colony-stimulating factors in febrile neutropenic cancer patients. A systematic review of the literature with meta-analysis.

Novel effects with polyethylene glycol modified pharmaceuticals.

P304

667-676

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/14796694.2.6.667

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17155894

http://www.w3.org/2001/XMLSchema#string